G2 Capital Management’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$207K Buy
766
+155
+25% +$46.2K 0.05% 72
2025
Q4
$202K Buy
611
+14
+2% +$4.74K 0.05% 69
2025
Q3
$206K Buy
+597
New +$181K 0.05% 68
2025
Q2
Sell
-562
Closed -$295K 68
2025
Q1
$295K Buy
562
+5
+0.9% +$2.56K 0.09% 58
2024
Q4
$282K Buy
557
+2
+0.4% +$1.14K 0.08% 56
2024
Q3
$324K Buy
555
+2
+0.4% +$1.13K 0.1% 52
2024
Q2
$282K Buy
553
+2
+0.4% +$980 0.09% 55
2024
Q1
$272K Buy
551
+2
+0.4% +$1.02K 0.09% 56
2023
Q4
$289K Buy
549
+17
+3% +$9.07K 0.1% 53
2023
Q3
$268K Sell
532
-12
-2% -$5.91K 0.12% 39
2023
Q2
$261K Hold
544
0.11% 41
2023
Q1
$257K Buy
544
+12
+2% +$5.79K 0.11% 52
2022
Q4
$282K Hold
532
0.1% 57
2022
Q3
$268K Hold
532
0.12% 47
2022
Q2
$273K Hold
532
0.13% 43
2022
Q1
$271K Sell
532
-608
-53% -$293K 0.12% 42
2021
Q4
$572K Buy
+1,140
New +$516K 0.21% 38

Other funds holding UNH

G2 Capital Management's UNH Position: Q1 2026 in Review

G2 Capital Management increased its UnitedHealth (UNH) stake by 25% in Q1 2026, buying an estimated $46.2K and bringing the position to 766 shares worth $207K. The position accounts for 0.05% of the portfolio, ranked #72.

G2 Capital Management first reported a position in UNH in Q4 2021 and has held it in 17 quarters since. The position peaked at $572K in Q4 2021. 3,020 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • G2 Capital Management held 766 shares of UnitedHealth worth $207K as of Q1 2026.
  • G2 Capital Management bought 155 UnitedHealth shares in Q1 2026, an estimated $46.2K.
  • UnitedHealth made up 0.05% of G2 Capital Management's portfolio in Q1 2026, its #72 holding.
  • G2 Capital Management first reported a position in UnitedHealth in Q4 2021 and has held it in 17 quarters since.
  • G2 Capital Management's UnitedHealth position peaked at $572K in Q4 2021.
  • 3,020 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on G2 Capital Management's 13F filing for Q1 2026, filed 12 May 2026.